Management of Hepatic Steatosis and Associated Conditions

Diagnostic Evaluation

The American College of Radiology suggests that diffusely increased hepatic echogenicity has 84.8% sensitivity and 93.6% specificity for moderate to severe hepatic fat deposition, making fatty liver the most likely diagnosis 2, 1
Comprehensive liver biochemistries, including ALT, AST, alkaline phosphatase, bilirubin, albumin, and INR, should be obtained to assess hepatocellular function and exclude acute hepatic injury 1
Screening for viral hepatitis and autoimmune markers is necessary to exclude alternative etiologies 1
Quantifying alcohol intake is crucial, as NAFLD diagnosis requires <14 drinks/week for women or <21 drinks/week for men 1

The NAFLD Fibrosis Score and FIB-4 Index should be calculated using age, BMI, platelet count, albumin, and transaminases to stratify fibrosis risk 1
Elastography-based assessment, such as transient elastography or ARFI, should be performed if intermediate or high risk to evaluate liver stiffness as a surrogate for fibrosis 1
Liver biopsy remains the gold standard when clinical uncertainty exists, particularly given concerning features of ascites and splenomegaly 1

The American College of Gastroenterology recommends optimizing metabolic comorbidities aggressively, including diabetes control, hypertension management, and dyslipidemia treatment, as the cornerstones of NAFLD therapy 1
Implementing lifestyle modifications, such as weight loss of 7-10% body weight, improves steatosis and inflammation 1
Discontinuing hepatotoxic medications and minimizing polypharmacy is essential in SNF settings 1
Arranging outpatient hepatology follow-up is necessary for ongoing risk stratification and surveillance 1

The European Association for the Study of the Liver recommends initiating hepatocellular carcinoma surveillance with semi-annual abdominal ultrasound with or without AFP if cirrhosis is confirmed 4
Screening for varices with upper endoscopy and initiating beta-blocker prophylaxis if present is necessary 3
Avoiding any procedure that could precipitate acute-on-chronic liver failure, including invasive interventions like embolization, is crucial 5
Considering early transplant evaluation if decompensated cirrhosis is confirmed, as 1-year survival is 78% with transplant versus <10% without 5

Ensuring adequate nutrition is essential, as patients with cirrhosis and ascites are at high risk for sarcopenia and malnutrition 6
Monitoring for hepatic encephalopathy and avoiding benzodiazepines and sedatives that can precipitate or worsen encephalopathy is necessary 7